| Product Code: ETC10939558 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The vaccine import shipments to Grenada in 2024 show a diversification in sources, with top exporting countries being Barbados, India, Panama, South Korea, and Belgium. This shift has led to a decrease in the Herfindahl-Hirschman Index (HHI) from high concentration in 2023 to moderate concentration in 2024. The impressive Compound Annual Growth Rate (CAGR) of 24.01% from 2020 to 2024 highlights the increasing demand for vaccines in Grenada. Moreover, the significant growth rate of 67.54% from 2023 to 2024 indicates a rapid expansion in the importation of vaccines, reflecting the country`s commitment to public health.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Vaccine Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Vaccine Market - Industry Life Cycle |
3.4 Grenada Vaccine Market - Porter's Five Forces |
3.5 Grenada Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.7 Grenada Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.8 Grenada Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Grenada Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Grenada Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Vaccine Market Trends |
6 Grenada Vaccine Market, By Types |
6.1 Grenada Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Vaccine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Grenada Vaccine Market Revenues & Volume, By Preventive Vaccines, 2021 - 2031F |
6.1.4 Grenada Vaccine Market Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031F |
6.1.5 Grenada Vaccine Market Revenues & Volume, By DNA Vaccines, 2021 - 2031F |
6.2 Grenada Vaccine Market, By Disease Indication |
6.2.1 Overview and Analysis |
6.2.2 Grenada Vaccine Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.3 Grenada Vaccine Market Revenues & Volume, By COVID19, 2021 - 2031F |
6.2.4 Grenada Vaccine Market Revenues & Volume, By Hepatitis B, 2021 - 2031F |
6.3 Grenada Vaccine Market, By Age Group |
6.3.1 Overview and Analysis |
6.3.2 Grenada Vaccine Market Revenues & Volume, By Pediatrics, 2021 - 2031F |
6.3.3 Grenada Vaccine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.3.4 Grenada Vaccine Market Revenues & Volume, By Geriatrics, 2021 - 2031F |
6.4 Grenada Vaccine Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Grenada Vaccine Market Revenues & Volume, By Intramuscular, 2021 - 2031F |
6.4.3 Grenada Vaccine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.4 Grenada Vaccine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Grenada Vaccine Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Grenada Vaccine Market Revenues & Volume, By mRNAbased, 2021 - 2031F |
6.5.3 Grenada Vaccine Market Revenues & Volume, By Viral Vector, 2021 - 2031F |
6.5.4 Grenada Vaccine Market Revenues & Volume, By Protein Subunit, 2021 - 2031F |
7 Grenada Vaccine Market Import-Export Trade Statistics |
7.1 Grenada Vaccine Market Export to Major Countries |
7.2 Grenada Vaccine Market Imports from Major Countries |
8 Grenada Vaccine Market Key Performance Indicators |
9 Grenada Vaccine Market - Opportunity Assessment |
9.1 Grenada Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.3 Grenada Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.4 Grenada Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Grenada Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Grenada Vaccine Market - Competitive Landscape |
10.1 Grenada Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Grenada Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here